RenovoRx (RNXT)

• Market cap: $34.5M
• 1 day: 4.5%
• 5 days: -5.95%
• 1 month: 28.4%
• 3 months: -29.29%
• 6 months: -31.85%
• Year to date: -30.85%
• 1 year: -18.22%
• 5 years: -87.05%
• 10 years: -87.05%
• Sector: Healthcare
• Industry: Biotechnology

About: RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Employees: 10